More than 1,500 industry leaders gathered at the WuXi Global Forum 2017. The annual event, held in San Francisco during the J.P. Morgan Healthcare Conference on Jan. 10, promotes new thinking on a global stage as we strive to find transformative models and solutions for patients, at a time when stakes are higher than ever for our industry.​ The WuXi Global Forum was co-sponsored by WuXi AppTec, BayHelix, BioCentury Inc., Biocom, BioWorld Today, ChinaBio, SVIEF, QB3, WuXi Healthcare Ventures, and Informa.

Speakers:

  • Ge Li, Founder, Chairman and CEO, WuXi AppTec
  • David Flores, President and CEO, BioCentury
  • Ryan Watts, CEO, Denali Therapeutics
  • Keith Leonard, CEO, Unity Biotechnology
  • Yujiro Hata, Co-Founder and CEO, IDEAYA Biosciences
  • Edward Hu, CFO and CIO, WuXi AppTec
  • Alexis Borisy, Partner, Third Rock Ventures
  • Shoucheng Zhang, Professor at Stanford University; Chairman, Danhua Capital
  • Yibing Wu, Joint Head of Portfolio Strategy & Risk Group and Joint Head of China, Temasek
  • Gregory Verdine, Erving Professor of Chemistry, Harvard University; CEO, FogPharma and LifeMine; Partner, WuXi Healthcare Ventures
  • John Reed, Head of Pharma Research and Early Development (pRED), Roche
  • Peter Schultz, CEO, The Scripps Research Institute and Calibr
  • Ken Drazan, Chief Business Officer, GRAIL
  • William Morice, Chair, Department of Laboratory Medicine and Pathology, Mayo Clinic; President, Mayo Medical Laboratories
  • Chad Robins, President and CEO, Adaptive Biotechnologies
  • Steve Yang, EVP and COO, WuXi AppTec
  • Lonnie Moulder, CEO, TESARO
  • Michael Yu, President and CEO, Innovent Biologics
  • Li Chen, CEO and Co-Founder, Hua Medicine
  • Mike Ward, Global Director of Content, Informa Pharma Insight
  • Sara Radcliffe, President and CEO, California Life Sciences Association
  • Hui Cai, VP of Corporate Alliances and Head of Communications, WuXi AppTec

Watch the recap video here.